increased circulating VLDL triglyceride level_Apoc2<em2Arem>/Apoc2<em2Arem>

http://metadb.riken.jp/0003975IC57BL6CBAApoc2em2AremApoc2em2AremApoc2em2Arem

increased circulating VLDL triglyceride level_Apoc2<em2Arem>/Apoc2<em2Arem>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• apolipoprotein C-II
  http://metadb.riken.jp/db/mgi_rdf/MGI:88054

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apoc2<em2Arem>/Apoc2<em2Arem>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Apoc2<em2Arem>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * CBA

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased circulating VLDL triglyceride level
  http://purl.obolibrary.org/obo/MP_0003975

文献

http://purl.org/net/cito/citesAsAuthority

• Toshihiro. Sakurai, et.al., Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide., The Journal of pharmacology and experimental therapeutics, 2016, 356
  http://rdf.ncbi.nlm.nih.gov/pubmed/26574515